We are live on !
Find out more
Aperio Group Portfolio holdings
AUM
$33.8B
Turnover
6.32%
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$264M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$52.4M |
| 2 |
Tesla
TSLA
|
+$42.1M |
| 3 |
Microsoft
MSFT
|
+$16.9M |
| 4 |
Walt Disney
DIS
|
+$14.5M |
| 5 |
Morgan Stanley
MS
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever NV New York Registry Shares
UN
|
+$48.8M |
| 2 |
AT&T
T
|
+$25.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$20M |
| 4 |
Amazon
AMZN
|
+$15.7M |
| 5 |
Biogen
BIIB
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.35% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
FB Financial Corp
FBK
$2.58B
| $327K | ﹤0.01% |
9,416
-2,244
| -19% | -$70.5K |
2020 Q3
1 quarter
|
|
2152
AdvanSix
ASIX
$417M
| $326K | ﹤0.01% |
16,322
+253
| +2% | +$4.34K |
2016 Q4
16 quarters
|
|
2153
Stoneridge
SRI
$169M
| $326K | ﹤0.01% |
10,786
-567
| -5% | -$14.7K |
2017 Q4
12 quarters
|
|
2154
Tejon Ranch
TRC
$433M
| $325K | ﹤0.01% |
22,502
+3,588
| +19% | +$52.3K |
2020 Q1
3 quarters
|
|
|
TPTX
2155
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $325K | ﹤0.01% |
+2,666
| New | +$292K |
2020 Q4
0 quarters
|
|
|
AXIA
2156
DELISTED
AXIA Energia
AXIA
| $322K | ﹤0.01% |
58,189
+4,564
| +9% | +$22.6K |
2016 Q4
16 quarters
|
|
2157
Texas Pacific Land
TPL
$23.7B
| $321K | ﹤0.01% |
3,978
-180
| -4% | -$11.4K |
2017 Q3
13 quarters
|
|
|
ISBC
2158
DELISTED
Investors Bancorp, Inc.
ISBC
| $321K | ﹤0.01% |
30,409
-3,885
| -11% | -$35.5K |
2016 Q3
17 quarters
|
|
2159
LendingTree
TREE
$373M
| $320K | ﹤0.01% |
1,167
-17
| -1% | -$5.05K |
2017 Q3
13 quarters
|
|
|
ZGNX
2160
DELISTED
Zogenix, Inc.
ZGNX
| $320K | ﹤0.01% |
16,037
-665
| -4% | -$13.6K |
2019 Q1
7 quarters
|
|
|
NGM
2161
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $319K | ﹤0.01% |
+10,526
| New | +$230K |
2020 Q4
0 quarters
|
|
2162
Lindsay Corp
LNN
$1.08B
| $318K | ﹤0.01% |
2,474
+159
| +7% | +$18.1K |
2013 Q4
28 quarters
|
|
2163
BioCryst Pharmaceuticals
BCRX
$1.98B
| $317K | ﹤0.01% |
42,614
+1,606
| +4% | +$8.28K |
2018 Q4
8 quarters
|
|
2164
Clean Energy Fuels
CLNE
$298M
| $316K | ﹤0.01% |
40,201
-2,935
| -7% | -$11.4K |
2020 Q2
2 quarters
|
|
2165
Veracyte
VCYT
$3.72B
| $315K | ﹤0.01% |
+6,431
| New | +$298K |
2020 Q4
0 quarters
|
|
2166
Lantheus
LNTH
$6.55B
| $313K | ﹤0.01% |
23,181
-514
| -2% | -$6.73K |
2020 Q1
3 quarters
|
|
2167
York Water
YORW
$496M
| $312K | ﹤0.01% |
6,691
+640
| +11% | +$29.3K |
2020 Q1
3 quarters
|
|
2168
Ambarella
AMBA
$2.91B
| $311K | ﹤0.01% |
+3,387
| New | +$237K |
2020 Q4
0 quarters
|
|
2169
Armour Residential REIT
ARR
$1.81B
| $311K | ﹤0.01% |
5,773
+346
| +6% | +$17.8K |
2017 Q2
14 quarters
|
|
2170
Monro
MNRO
$445M
| $311K | ﹤0.01% |
5,837
-1,140
| -16% | -$52K |
2014 Q4
24 quarters
|
|
2171
Tactile Systems Technology
TCMD
$527M
| $311K | ﹤0.01% |
6,914
-175
| -2% | -$6.95K |
2018 Q2
10 quarters
|
|
|
ICPT
2172
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $311K | ﹤0.01% |
12,575
+2,551
| +25% | +$84.5K |
2018 Q1
11 quarters
|
|
2173
NexPoint Residential Trust
NXRT
$462M
| $310K | ﹤0.01% |
7,322
+1,423
| +24% | +$62.3K |
2020 Q3
1 quarter
|
|
2174
Occidental Petroleum Corp Warrants
OXY.WS
$38.4B
| $309K | ﹤0.01% |
45,433
-60
| -0.1% | -$272 |
2020 Q3
1 quarter
|
|
2175
3D Systems Corp
DDD
$502M
| $308K | ﹤0.01% |
29,372
+1,914
| +7% | +$15.6K |
2015 Q3
21 quarters
|
|
Similar funds
LCM
Aperio Group's Q4 2020 Portfolio in Review
As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
- Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
- Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
- Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
- Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
- Aperio Group opened 104 new positions and closed 53 in Q4 2020.
- Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.